Thank you Scott Jacobsen and The Good Men Project for a great interview! Check out the full article below and find out how Orange Biomed is overcoming the limitations of current A1C testing with our novel technology application. #A1C #TheGoodMenProject
Find out how Yeaseul Park is striving to make A1C testing more accessible and affordable in her interview with The Good Men Project: bit.ly/3Vlp72I The Orange Biomed Co-Founder spoke with Scott Jacobsen to educate audiences on the current limitations of A1C testing and how OBM rapid A1c seeks to overcome them. While existing at-home A1C devices use protein quantification methods, which are complicated and require trained professionals to operate, OBM rapid A1c doesn’t use protein reagents, making it easy for anyone to obtain accurate results. Traditional A1C tests can also produce inaccurate A1C readings due to hemoglobin variants, which are more common among Black, Hispanic, and Asian American populations, unlike Orange Biomed's novel technology application. “Theoretically, hemoglobin variants can’t affect our device because they don't involve identifying proteins. This principle allows us to overcome the limitations of current devices, particularly point-of-care ones.” - Yeaseul Park. Read the full article to learn more about how the OBM rapid A1c is revolutionizing POC A1C testing: bit.ly/3Vlp72I #A1C #TheGoodMenProject #A1CTesting #A1C #HealthTech #DiabetesInnovation #DiabetesTesting #HealthcareRevolution #OrangeBiomed #Diabetes #DiabetesCare #Microfluidics #MicrofluidicDevices #PreDiabetes #Type1 #Type2